MENU

Are cheap value ASX shares about to create the best returns?

‘Value’ ASX shares that are cheap could soon be the best ones to own.

There has been an increasing amount of discussion about whether ‘growth’ or ‘value’ is the best way to go for share investing.

I’m not sure there is such a thing as ‘value’ investing. Surely we are all trying to buying shares for cheaper than what we think they are, no matter if they have a current price/earnings ratio of 10 or 40?

It is true to say that shares with high(er) p/e ratios have been the strongest performers on the ASX over the past year or two such as Altium Limited (ASX: ALU) and WiseTech Global Ltd (ASX: WTC).

Investment returns are decided by: the dividends paid, earnings growth and the price the market is willing to pay for those earnings. The market has decided to pay a much higher price for those earnings of businesses that display good earnings growth.

However, with rising interest rates and high valuations of ‘growth’ businesses, it may be time for businesses with low valuations to outperform. Indeed, those same high-flyers are now registering some of the biggest losses over the past few months.

It can be fairly hard to find shares that are trading at low valuations and are still growing. Sometimes those low p/e shares can actually be a trap. The price may have fallen first, but the earnings may then be reported lower, bringing the p/e back up a reasonable level.

Foolish takeaway

Two of the low valuation shares that I feel could be good medium-term buys at the current prices are: regional livestock & pet veterinary business Apiam Animal Health Ltd (ASX: AHX) which is trading at 9x FY19’s estimated earnings and healthcare product distribution business Paragon Care Ltd (ASX: PGC) which is trading at 10.5x FY19’s estimated earnings.

Want some other ideas of shares that are trading at good value, yet have good growth prospects? These leading ASX shares could all be winners.

3 Good Value Growth Shares For Your Portfolio

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Altium, Apiam Animal Health Ltd, and Paragon Care Limited. The Motley Fool Australia owns shares of Altium and WiseTech Global. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!